tm logo
CYTEGRITY
FORMALIZED

on 05 Jun 2024

Last Applicant/ Owned by

CSL BEHRING GENE THERAPY INC.

Suite 650,35 N. Lake AvenuePasadena CA 91101

US

Serial Number

2331070 filed on 13th Feb 2024

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

CYTEGRITY

Trademark usage description

cell lines for scientific and research use; cells for scientific, laboratory or medical research; biological preparations, namely, viral vectors and g Read More

Classification Information


Class [001]
Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines; cell lines for gene expression, and for synthesis of biological compounds; cells for gene expression and for synthesis of biological compounds; viral vectors.


Classification kind code

12

Class [005]
Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for gene therapy; gene therapy vectors.


Classification kind code

12

Mark Details


Serial Number

2331070

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 11th Sep 2024
Agent Changed
Submitted for opposition 257
on 06th Jun 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 05th Jun 2024
Created
Submitted for opposition 31
on 05th Jun 2024
Formalized
Submitted for opposition 30
on 13th Feb 2024
Filed
Submitted for opposition 228
on 13th Feb 2024
International Registration